Global Competent Cells Market is expected to reach USD
2777.89 million by 2029 with CAGR of 8.4% between 2023 and 2029
Competent cells incorporate foreign DNA through altered cell walls to pass DNA more easily. Calcium chloride and Heat shock treatment are used to make cell “competent”. Electroporation is a process that includes brief exposure of cells to an electric field in order to pass DNA through it. Cells undergoing very rapid growth can be made competent easily than cells in other development phase. Bacterial culture has varies growth rate, in initial hours called lag phase with small number of dividing cells growth rate is low. In rapid growth phase also called Log phase under proper temperature cells can become competent easily.
Competent Cells Market: Competence Type
Competence is distinguished based on the environment used to perform on bacterial cell transformation .Basically Competence type are:
Natural Competence
Cells are able to receive DNA from their environment by :
Conjugation
transformation
transduction
In transformation the DNA is directly pass into the cell. In order to receive transforming DNA recipient cells should be in a specialized physiological state called log phase or competent state.
Artificial Competence
Artificial competence includes setting specific artificial conditions in which cells are made permeable to DNA in laboratory. It is relatively easy competence procedure and can be used in the genetic engineering of bacteria. Artificial competence is low efficiency process as cells are forces to adopt foreign DNA.
Competent Cells Market: Growth Outlook
Technological advancement and increasing need of genomic and protein expressed products are prime factors contributing to growth of Competent Cells Market.
Competent Cells Market: Product Type
Chemically Competent Cells
Electrocompetent Cells
Competent Cells Market : Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
Global Competent Cells Market: Competitive Analysis
Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study constitutes of following key players in Global Competent Cells Market:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
Geographical analysis of Competent Cells Market:
North America
U.S.A
Canada
Europe
France
Germany
Spain
UK
Rest of Europe
Asia Pacific
China
Japan
India
South East Asia
Latin America
Brazil
Middle East and Africa
Competent Cells Market Report delivers comprehensive analysis of :
Market Forecast for 2020-28
Market growth drivers
Challenges and Opportunities
Emerging and Current market trends
Market player Capacity, Production, Revenue (Value)
Competent Cells Market was valued at around USD 1344.16 million in 2022 & estimated to reach USD 2777.89 million by 2029.
Competent Cells Market is likely to grow at compounded annual growth rate (CAGR) of 8.4% between 2023 to 2029.
North America accounts for the largest industry share for Competent Cells Market in 2019.
Some of the top companies included in the research report are Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen.
Technological advancement and increasing need of genomic and protein expressed products are prime factors contributing to growth of Competent Cells Market.
Yes, the report includes COVID 19 impact on the market.
